en

PRODUCT DETAIL

Abevmy 25 mg/ml infúzny koncentrát

Code 7463D
MA number EU/1/20/1515/005
Product Form: con inf 3x16 ml/400 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XC Monoclonal antibodies
L01XC07 Bevacizumab
Shelf life: 24
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 21.04.2021
Validity: 21.04.2026
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 27.04.2021
eu-flag.png sk-flag.png